Corinna Panlilio Sison, MD

Director, Clinical Strategy https://www.endocrinologyadvisor.com

Corinna Panlilio Sison, MD, is the director of clinical strategy for the Haymarket Medical Network, part of the Medical Communications Group of Haymarket Media. She received her BA in biology from the University of Pennsylvania and her MD from the University of Medicine and Dentistry of New Jersey.

All articles by Corinna Panlilio Sison, MD

Type 1 Diabetes

Younger Age, Female Sex, and HbA1c Linked to C-Peptide Decline in Pediatric T1D

Corinna Panlilio Sison, MD

November 12, 2020

Investigators sought to determine whether younger age at diagnosis, female sex, and higher weight z score and HbA1c are risk factors for C-peptide decline after new onset of pediatric type 1 diabetes.

ENDO 2016

Abaloparatide Decreased Fractures in Postmenopausal Women With Osteoporosis

Corinna Panlilio Sison, MD

April 18, 2016

The efficacy and safety of abaloparatide was studied in a randomized, double-blind, multicenter trial evaluating fracture prevention in ambulatory, postmenopausal women with osteoporosis.

Next post in ENDO 2016

Corinna Panlilio Sison, MD

All articles by Corinna Panlilio Sison, MD

Younger Age, Female Sex, and HbA1c Linked to C-Peptide Decline in Pediatric T1D

Abaloparatide Decreased Fractures in Postmenopausal Women With Osteoporosis

VIDEO: Diabetes Technology: An Endocrine Society Clinical Practice Guideline